The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved..
Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated thyroid cancers, yet the molecular origins of its aggressivity are unknown. We sequenced tumor DNA from 329 regions of thyroid cancer, including 213 from patients with primary anaplastic thyroid carcinomas. We also whole genome sequenced 9 patients using multi-region sequencing of both differentiated and anaplastic thyroid cancer components. Using these data, we demonstrate thatanaplastic thyroid carcinomas have a higher burden of mutations than other thyroid cancers, with distinct mutational signatures and molecular subtypes. Further, different cancer driver genes are mutated in anaplastic and differentiated thyroid carcinomas, even those arising in a single patient. Finally, we unambiguously demonstrate that anaplastic thyroid carcinomas share a genomic origin with co-occurring differentiated carcinomas and emerge from a common malignant field through acquisition of characteristic clonal driver mutations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Cell reports - 43(2024), 3 vom: 26. März, Seite 113826 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zeng, Peter Y F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anaplastic thyroid cancer |
|---|
| Anmerkungen: |
Date Completed 01.04.2024 Date Revised 06.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.celrep.2024.113826 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369020529 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369020529 | ||
| 003 | DE-627 | ||
| 005 | 20240406232211.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.celrep.2024.113826 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1367.xml |
| 035 | |a (DE-627)NLM369020529 | ||
| 035 | |a (NLM)38412093 | ||
| 035 | |a (PII)S2211-1247(24)00154-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zeng, Peter Y F |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The genomic and evolutionary landscapes of anaplastic thyroid carcinoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2024 | ||
| 500 | |a Date Revised 06.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated thyroid cancers, yet the molecular origins of its aggressivity are unknown. We sequenced tumor DNA from 329 regions of thyroid cancer, including 213 from patients with primary anaplastic thyroid carcinomas. We also whole genome sequenced 9 patients using multi-region sequencing of both differentiated and anaplastic thyroid cancer components. Using these data, we demonstrate thatanaplastic thyroid carcinomas have a higher burden of mutations than other thyroid cancers, with distinct mutational signatures and molecular subtypes. Further, different cancer driver genes are mutated in anaplastic and differentiated thyroid carcinomas, even those arising in a single patient. Finally, we unambiguously demonstrate that anaplastic thyroid carcinomas share a genomic origin with co-occurring differentiated carcinomas and emerge from a common malignant field through acquisition of characteristic clonal driver mutations | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a CP: Cancer | |
| 650 | 4 | |a CP: Genomics | |
| 650 | 4 | |a anaplastic thyroid cancer | |
| 650 | 4 | |a cancer progression | |
| 650 | 4 | |a genomics | |
| 650 | 4 | |a tumour evolution | |
| 650 | 4 | |a tumour heterogeneity | |
| 700 | 1 | |a Prokopec, Stephenie D |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Stephen Y |e verfasserin |4 aut | |
| 700 | 1 | |a Pinto, Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Chan-Seng-Yue, Michelle A |e verfasserin |4 aut | |
| 700 | 1 | |a Clifton-Bligh, Roderick |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Michelle D |e verfasserin |4 aut | |
| 700 | 1 | |a Howlett, Christopher J |e verfasserin |4 aut | |
| 700 | 1 | |a Plantinga, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Cecchini, Matthew J |e verfasserin |4 aut | |
| 700 | 1 | |a Lam, Alfred K |e verfasserin |4 aut | |
| 700 | 1 | |a Siddiqui, Iram |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jianxin |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Ren X |e verfasserin |4 aut | |
| 700 | 1 | |a Watson, John D |e verfasserin |4 aut | |
| 700 | 1 | |a Korah, Reju |e verfasserin |4 aut | |
| 700 | 1 | |a Carling, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Nishant |e verfasserin |4 aut | |
| 700 | 1 | |a Cipriani, Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Ball, Douglas |e verfasserin |4 aut | |
| 700 | 1 | |a Nelkin, Barry |e verfasserin |4 aut | |
| 700 | 1 | |a Rooper, Lisa M |e verfasserin |4 aut | |
| 700 | 1 | |a Bishop, Justin A |e verfasserin |4 aut | |
| 700 | 1 | |a Garnis, Cathie |e verfasserin |4 aut | |
| 700 | 1 | |a Berean, Ken |e verfasserin |4 aut | |
| 700 | 1 | |a Nicolson, Norman G |e verfasserin |4 aut | |
| 700 | 1 | |a Weinberger, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Henderson, Ying C |e verfasserin |4 aut | |
| 700 | 1 | |a Lalansingh, Christopher M |e verfasserin |4 aut | |
| 700 | 1 | |a Tian, Mao |e verfasserin |4 aut | |
| 700 | 1 | |a Yamaguchi, Takafumi N |e verfasserin |4 aut | |
| 700 | 1 | |a Livingstone, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Salcedo, Adriana |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Krupal |e verfasserin |4 aut | |
| 700 | 1 | |a Vizeacoumar, Frederick |e verfasserin |4 aut | |
| 700 | 1 | |a Datti, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Xi, Liu |e verfasserin |4 aut | |
| 700 | 1 | |a Nikiforov, Yuri E |e verfasserin |4 aut | |
| 700 | 1 | |a Smallridge, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Copland, John A |e verfasserin |4 aut | |
| 700 | 1 | |a Marlow, Laura A |e verfasserin |4 aut | |
| 700 | 1 | |a Hyrcza, Martin D |e verfasserin |4 aut | |
| 700 | 1 | |a Delbridge, Leigh |e verfasserin |4 aut | |
| 700 | 1 | |a Sidhu, Stan |e verfasserin |4 aut | |
| 700 | 1 | |a Sywak, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Robinson, Bruce |e verfasserin |4 aut | |
| 700 | 1 | |a Fung, Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Ghasemi, Farhad |e verfasserin |4 aut | |
| 700 | 1 | |a Kwan, Keith |e verfasserin |4 aut | |
| 700 | 1 | |a MacNeil, S Danielle |e verfasserin |4 aut | |
| 700 | 1 | |a Mendez, Adrian |e verfasserin |4 aut | |
| 700 | 1 | |a Palma, David A |e verfasserin |4 aut | |
| 700 | 1 | |a Khan, Mohammed I |e verfasserin |4 aut | |
| 700 | 1 | |a Shaikh, Mushfiq |e verfasserin |4 aut | |
| 700 | 1 | |a Ruicci, Kara M |e verfasserin |4 aut | |
| 700 | 1 | |a Wehrli, Bret |e verfasserin |4 aut | |
| 700 | 1 | |a Winquist, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Yoo, John |e verfasserin |4 aut | |
| 700 | 1 | |a Mymryk, Joe S |e verfasserin |4 aut | |
| 700 | 1 | |a Rocco, James W |e verfasserin |4 aut | |
| 700 | 1 | |a Wheeler, David |e verfasserin |4 aut | |
| 700 | 1 | |a Scherer, Steve |e verfasserin |4 aut | |
| 700 | 1 | |a Giordano, Thomas J |e verfasserin |4 aut | |
| 700 | 1 | |a Barrett, John W |e verfasserin |4 aut | |
| 700 | 1 | |a Faquin, William C |e verfasserin |4 aut | |
| 700 | 1 | |a Gill, Anthony J |e verfasserin |4 aut | |
| 700 | 1 | |a Clayman, Gary |e verfasserin |4 aut | |
| 700 | 1 | |a Boutros, Paul C |e verfasserin |4 aut | |
| 700 | 1 | |a Nichols, Anthony C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell reports |d 2012 |g 43(2024), 3 vom: 26. März, Seite 113826 |w (DE-627)NLM217067492 |x 2211-1247 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2024 |g number:3 |g day:26 |g month:03 |g pages:113826 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.celrep.2024.113826 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2024 |e 3 |b 26 |c 03 |h 113826 | ||